The Swiss bank UBS said it had concluded in February that buying its rival Credit Suisse was not desirable, but that it should prepare in case the bank encountered “serious financial difficulties”.
This content was published on
2 minutes
Reuters/sb
Italiano
it
UBS diffida dell’acquisto di Credit Suisse a febbraio, come risulta da un documento statunitense
In a filing to the US Securities and Exchange Commission, dated April 26, UBS said it had been mulling the potential impact of a Credit Suisse deal since December, Reuters reported on Wednesday.
In March, UBS agreed to take over Credit Suisse for CHF3 billion ($3.37 billion) and said it would assume up to CHF5 billion in losses, as part of a government-backed rescue that is backed by as much as CHF250 billion of state support.
The Swiss authorities and UBS Group AG have been racing to close the takeover as soon as possible in an effort to retain the lender’s clients and employees.
UBS Chief Executive Sergio Ermotti said on Wednesday that the Swiss bank was working on closing its merger with Credit Suisse by the end of May or early June.
Speaking at the Finanz ’23 conference in Zurich, Ermotti also repeated his bank’s line that all options were still on the table concerning Credit Suisse’s Swiss business.
In the US filing, UBS said that the merger still required approval from regulators in the European Union, India, Japan, Mexico and South Korea.
Last month, UBS secured temporary approval from EU antitrust regulators, while the US Federal Reserve approved the UBS Group’s acquisition of Credit Suisse’s US subsidiaries.
Popular Stories
More
Multinational companies
Azeri fossil-fuel cash cow brings controversy to Switzerland
Is artificial intelligence an advantage or a disadvantage for workers?
What is your experience with AI at work? Have you already used it? Has it helped you work better? Or has it caused you more stress, more work or caused you to lose your job? Tell us about your experiences!
Swiss price watchdog slams excessive prices for generic medicines
This content was published on
The cheapest generic medicines available in Switzerland are more than twice as expensive as in other countries, according to a study by the Swiss price watchdog.
Nature should not figure in net zero calculations: academic study
This content was published on
The natural removal of CO2 from the atmosphere by forests or oceans should not be included in the net-zero balance of climate protection measures, argue researchers.
This content was published on
None of the 15 major Swiss retail banks is meeting international climate and biodiversity targets, according to a ranking by WWF Switzerland.
This content was published on
Nestlé's new CEO Laurent Freixe, has presented plans for the future of the world's largest food company, after his first few weeks in office.
Swiss foreign minister calls on Moscow to end Ukraine war
This content was published on
It's high time Moscow ended its war against Ukraine, Swiss foreign minister Ignazio Cassis tells the UN Security Council.
This content was published on
The only alternative to the UN Palestinian agency’s work in Gaza is to allow Israel to run services there, Philippe Lazzarini, UNRWA Commissioner-General, told reporters in Geneva on Monday.
Study reveals food culture differences between Switzerland and neighbours
This content was published on
Three-quarters of Swiss people consider eating to be a pleasurable, social activity, a new survey reveals. Healthy eating, however, plays a much less important role, it found.
Credit Suisse agrees to CHF3bn takeover by rival Swiss bank UBS
This content was published on
Ailing Swiss bank Credit Suisse will be taken over by its rival UBS after a frantic last-ditch deal to prevent a catastrophic banking collapse.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.